News & Events article_type All Event News Press Reset Sort by year Show All 2019 2020 2021 2022 2023 2024 2025 Reset Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease 06.26.25 Press Read Article Ted Myles Joins Cellarity as Chief Executive Officer 05.12.25 Press Read Article Biotech2050 Podcast: Cellarity CEO Fabrice Chouraqui on how AI/ML are Revolutionizing Drug Discovery 08.28.24 Podcast Read Article Cellarity Appoints Percy Carter, MBA, Ph.D., as Member of Board of Directors 07.25.24 Press Read Article Cellarity Appoints Head of Platform to Advance Vision for Novel Drug Creation 05.07.24 Press Read Article Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases 01.04.24 News Read Article Cellarity Announces the Expansion of Its Partnership with Novo Nordisk to Discover and Develop a Novel Treatment in Metabolic Steatohepatitis (MASH) Using Its Innovative Platform 01.04.24 News Read Article Cellarity to Present at the 42nd Annual J.P. Morgan Healthcare Conference 01.03.24 News Read Article Cellarity Named a Top Place to Work for 2023 by The Boston Globe 12.04.23 News Read Article Cellarity Announces Partnership with Chan Zuckerberg Initiative to Advance New Machine Learning Algorithms for Single-Cell Analysis 10.17.23 News Read Article Load More
